InvestorsHub Logo
Followers 205
Posts 9788
Boards Moderated 6
Alias Born 10/02/2010

Re: TEXASOIL post# 365

Friday, 10/15/2010 11:32:55 PM

Friday, October 15, 2010 11:32:55 PM

Post# of 1064
texasoil,

There has been no change in the share structure from what I have seen.

1.5B A/S common with 10M A/S preferred.

The company is inactive in Florida, and in default in Nevada.

Not much trading activity in Frankfurt either. (YT3)

It is an interesting shell though. YAGI got the company assets in the chapter 11 settlement, but It seems that Silvasan retained the empty shell. (IMO)

Several former TLPEQ officers are involved in Marius Silvasan's private company Abacus World Corp.

Abacus provides services to private companies that wish to go public.

Abacus has recently taken a private company public and it has just been approved to trade on the Nasdaq.

And now, These TLPEQ officers seem to have an inactive shell that could be used for a similar deal.

All IMO and FWIW of course.

MIAMI, FL – June 24th, 2008 – Abacus World, Corp. (www.abacusworldcorp.com) (“Abacus” or the “Company”), a business advisory firm catered to help small and midsized companies reach their full potential, announced that it has entered into an agreement with Sanming Hujian Bioengineering Co., LTD (“Sanming”) to provide certain services.

As part of the agreement, Abacus is to provide services which include, but are not limited to, bringing Sanming public in the United States, providing general consulting and advisory services, and introducing Sanming to institutional investors and high net worth individuals to raise capital for growth.

“We are very pleased with the Sanming engagement. We have focused resources and energy in the last few months in developing our Asian presence. We are focused in growing our portfolio of good profitable businesses in select markets. We strongly believe the Asian market, with China in particular, is well positioned to deliver sustainable growth. Our strategy is to place investors into winning companies and assist said companies to reach their strategic growth and profit objectives,” stated Michael Karpheden, CEO and President of Abacus.

“We are confident that we have selected the right partner in Abacus to bring our firm public in the United States and assist us reaching our operational objectives while maximizing returns to our investors. We look forward to a long term relationship with Abacus. The market for our products which includes Solanesol, Nicotine Sulphate and CoQ10 is in high growth and are determined to take a large part of that market,” stated Mr. Min Zhao Sanming’s CEO and President.





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.